Glaukos Corporation Alternatives & Competitors
12 companies similar to Glaukos Corporation — Pioneering new treatments for chronic eye diseases
Companies similar to Glaukos Corporation
Tesu Health
Evidence-based digital therapeutics platform for personalised management of chronic diseas...
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Affinia Therapeutics
Building the next generation of gene therapies
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Rival Readout
Competing with Glaukos Corporation? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
Vantage Biosciences
Transforming diabetic eye disease with an oral treatment
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Kynexis
Kynexis is advancing the first potential precision medicine for the treatment of CIAS.
Intellia Therapeutics, Inc.
Developing curative genome editing treatments
About Glaukos Corporation
Glaukos Corporation, a company founded in 1998, is making significant strides in the field of healthcare, specifically within the realms of chronic eye disease treatment. With the bold slogan, "Pioneering new treatments for chronic eye diseases," the company is deeply engaged in the development of innovative therapies...
Development of novel ophthalmic therapies, Clinical support and educational resources, Sustained-release drug delivery platforms, Cross-linking interventions for keratoconus
Ophthalmologists, Patients with chronic eye diseases, Healthcare providers practicing in eye care
Ophthalmic Medical Technology, Glaucoma Treatment, Micro-Invasive Glaucoma Surgery, MIGS, IStent, Corneal Disorders, Retinal Diseases, FDA Approved Medical Device, Injectable Micro-scale Therapies, Glaucoma Disease Progression, Initial Public Offering, San Clemente-based Company, Corneal Crosslinking, Keratoconus Treatment, Innovative Eye Care Solutions
B2B, D2C, B2D
Product Sales, Service Fee, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Glaukos Corporation: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Glaukos Corporation on 13 Mar 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 20 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.